Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Go back to Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 74.55 -0.5 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.05 | 52 Week High | $18.39 | |||
| Open | $74.54 | 52 Week Low | $6.96 | |||
| Day High | $74.63 | P/E | N/A | |||
| Day Low | $74.48 | EPS | $-0.58 | |||
| Volume | 22,759 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1138.37 -14.17 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.54 | 52 Week High | $88.16 | |||
| Open | $1146.96 | 52 Week Low | $67.88 | |||
| Day High | $1150.05 | P/E | 263.51 | |||
| Day Low | $1136.56 | EPS | $4.32 | |||
| Volume | 132,583 | |||||
| Medtronic Inc. (NYSE: MDT) | Delayed: 80.10 +0.80 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.30 | 52 Week High | $89.27 | |||
| Open | $79.61 | 52 Week Low | $71.03 | |||
| Day High | $80.50 | P/E | 22.76 | |||
| Day Low | $79.50 | EPS | $3.52 | |||
| Volume | 222,851 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 49.72 +0.65 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.07 | 52 Week High | $59.00 | |||
| Open | $49.36 | 52 Week Low | $32.80 | |||
| Day High | $49.79 | P/E | N/A | |||
| Day Low | $49.36 | EPS | $0.00 | |||
| Volume | 516,196 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.10 -0.08 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.18 | 52 Week High | $44.76 | |||
| Open | $43.09 | 52 Week Low | $36.81 | |||
| Day High | $43.15 | P/E | N/A | |||
| Day Low | $43.04 | EPS | $0.00 | |||
| Volume | 86,948 | |||||

